Various Pharmaceutical Items

Award Notice Posted

Solicitation number
VA-797-10-RP-0028
Agency
Awarded
to Mylan Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
VA797P0206 Federal IDV award
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

Added: Jan 20, 2010 8:06 am Modified: Jan 20, 2010 11:41 amTrack Changes PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) VA-797-10-RP-0028 under competitive negotiated procedures for numerous pharmaceutical items. Please see Attachment "A" for the list of the items and estimated annual usage. The estimated annual usage includes VA, DoD, Indian Health Service (IHS), and Bureau of Prisons (BOP). The contract period will be for one year plus four pre-priced option periods. The contract items will be distributed through VA's and DoD's respective Pharmaceutical Prime Vendors.

This procurement is subject to the requirements of the Trade Agreements Act, *except that offers from countries not covered by any Free Trade Agreement will be considered if, and only if, no offers are received from U.S. made or from Trade Agreement designated countries pursuant to Federal Acquisition Regulation Part 25.403(c) and/or the items being procured are not on a government-wide contract. Each solicitation line item will represent separate requirements for the purpose of Federal Acquisition Regulation Clause 52.217-9, "Option to Extend the Term of the Contract" and FAR Clause 52.233-3, "Service of Protest." A separate determination on the exercise of subsequent contract options will be made individually per solicitation line item awarded.



Products offered must be FDA compliant. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and products proposed must have unique NDC numbers. Capsules must be compatible with automated dispensing units (Baxter ATC Canisters, Optifil, etc.). If the offeror is not a manufacturer, a signed agreement between the offeror and the manufacturer must be submitted with the offer.. Solicitation No VA-797-10-RP-0028 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 3, 2010, with an estimated closing date of February 24, 2010. The NAICS code for this procurement is 325412 and *Numbered Note 12 applies. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Wenzbauer. Questions can be e-mailed to: james.wenzbauer2@va.gov



























ATTACHMENT A

DESCRIPTION Total Estimated Annual Usage

ACETIC ACID 2% HYDROCORTASONE 1% OTIC 10ML 18,669

ALBUTEROL 2MG TAB 100 4,335

ALBUTEROL 4MG TAB 100 7,662

ANAGRELIDE 0.5MG 100 7,303

ANAGRELIDE 1MG 100 1,245

BACITRACIN OPTH OINT 1/8 OZ 61,562

CHLORDIAZEPOXIDE 10MG CAP 100 13,641

CHLORDIAZEPOXIDE 25MG CAP 100 8,471

CHLORDIAZEPOXIDE 5MG CAP 100 4,265

CLOBETASOL PROPIONATE 0.05% OINTMENT 15GM 29,305

CLOBETASOL PROPIONATE 0.05% OINTMENT 30GM 127,541

CLOBETASOL PROPIONATE 0.05% OINTMENT 45GM 28,308

CLOBETASOL PROPIONATE 0.05% OINTMENT 60GM 16,511

CLOBETASOL PROPIONATE 0.05% CREAM 15GM 29,481

CLOBETASOL PROPIONATE 0.05% CREAM 30GM 84,912

CLOBETASOL PROPIONATE 0.05% CREAM 45GM 9,105

CLOBETASOL PROPIONATE 0.05% CREAM 60GM 17,264

CLOMIPRAMINE HCL 50MG CAP 100 4,823

DILTIAZEM HCL 120MG TAB 100 5,644

DILTIAZEM HCL 30MG TAB 100 6,017

DILTIAZEM HCL 30MG TAB 500 2,717

DILTIAZEM HCL 60MG TAB 100 10,944

DILTIAZEM HCL 60MG TAB 500 3,145

DILTIAZEM HCL 90MG TAB 100 9,080

ATROPINE SO4 0.025MG/DIPHENOXYLATE HCL 2.5MG TAB 100 53,548

DISOPYRAMIDE CAP 100MG 100 1,948

DISOPYRAMIDE CAP 150MG 100 2,789

ESTRADIOL TAB 0.5MG 100 7,872

ESTRADIOL TAB 1MG 100 10,845

ESTRADIOL TAB 2MG 100 4,600

FAMOTIDINE 20MG UU 100 6,369

FAMOTIDINE 40MG UU 100 6,584

GLYBURIDE MICRONIZED TAB 1.5MG 100 2,929

GLYBURIDE MICRONIZED TAB 3MG 100 20,977

GLYBURIDE MICRONIZED TAB 6MG 100 10,500

NADOLOL 20MG TAB 100 5,843

NADOLOL 40MG TAB 100 8,266

NADOLOL 80MG TAB 100 2,594

PHENAZOPYRIDINE HCL 100MG TAB 100 27,307

PHENAZOPYRIDINE HCL 200MG TAB 100 5,398

PROCHLORPERAZINE TAB 10MG 100 25,902

PROCHLORPERAZINE TAB 5MG 100 16,539

SPIRONOLACTONE/HCTZ 25-25 TAB 100 3,934

SPIRONOLACTONE/HCTZ 25-25 TAB 500 836

THIOTHIXENE HCL 10MG CAP 100 4,746

THIOTHIXENE HCL 2MG CAP 100 2,583

THIOTHIXENE HCL 5MG CAP 100 4,782

ZALEPLON 10MG CAP 100 6,360

ZALEPLON 5MG CAP 100 1,294

VERAPAMIL HCL 80MG TAB 100 7,067

VERAPAMIL HCL 80MG TAB 500 1,974

or or

VERAPAMIL HCL 80MG TAB 1000 987

VERAPAMIL HCL 120MG TAB 100 8,474

VERAPAMIL HCL 120MG TAB 500 1,968

or or

VERAPAMIL HCL 120MG TAB 1000 984

VERAPAMIL HCL 40MG TAB 100 1,828

BUMETANIDE 0.5MG TAB 100 5,674

BUMETANIDE 1MG TAB 500 7,412

OR

BUMETANIDE 1MG TAB 1000 3,706

BUMETANIDE 2MG TAB 500 4,192

OR

BUMETANIDE 2MG TAB 1000 2,096

CAFFEINE 100MG/ERGOTAMINE TARTRATE 1MG TAB 100 6,433

DANAZOL 100MG CAP 100 272

DANAZOL 200MG CAP 100 1,164

DANAZOL 50MG CAP 100 223

DOXEPIN HCL 150MG CAP 100 1,463

MEXILETINE HCL 150MG CAP 100 6,638

MEXILETINE HCL 200MG CAP 100 3,847

MEXILETINE HCL 250MG CAP 100 436

NEFAZODONE 100MG TAB 60 8,418

NEFAZODONE 150MG TAB 60 9,848

NEFAZODONE 200MG TAB 60 16,232

NEFAZODONE 250MG TAB 60 1,545

NEFAZODONE 50MG TAB 100 381

PROPYLTHIOURACIL 50MG TAB 100 13,104

TOLMETIN NA 200MG TAB 100 610

Update #1 ·

Added: Jan 20, 2010 8:06 am PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) VA-797-10-RP-0028 under competitive negotiated procedures for numerous pharmaceutical items. Please see Attachment "A" for the list of the items and estimated annual usage. The estimated annual usage includes VA, DoD, Indian Health Service (IHS), and Bureau of Prisons (BOP). The contract period will be for one year plus four pre-priced option periods. The contract items will be distributed through VA's and DoD's respective Pharmaceutical Prime Vendors.

This procurement is subject to the requirements of the Trade Agreements Act, *except that offers from countries not covered by any Free Trade Agreement will be considered if, and only if, no offers are received from U.S. made or from Trade Agreement designated countries pursuant to Federal Acquisition Regulation Part 25.403(c) and/or the items being procured are not on a government-wide contract. Each solicitation line item will represent separate requirements for the purpose of Federal Acquisition Regulation Clause 52.217-9, "Option to Extend the Term of the Contract" and FAR Clause 52.233-3, "Service of Protest." A separate determination on the exercise of subsequent contract options will be made individually per solicitation line item awarded.



Products offered must be FDA compliant. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and products proposed must have unique NDC numbers. Capsules must be compatible with automated dispensing units (Baxter ATC Canisters, Optifil, etc.). If the offeror is not a manufacturer, a signed agreement between the offeror and the manufacturer must be submitted with the offer.. Solicitation No VA-797-10-RP-0028 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 3, 2010, with an estimated closing date of February 24, 2010. The NAICS code for this procurement is 325412 and *Numbered Note 12 applies. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Wenzbauer. Questions can be e-mailed to: james.wenzbauer2@va.gov

Files

File Type Posted
VA-797-10-RP-0028-0001000.DOC DOC document
VA-797-10-RP-0028-000.DOC DOC document

Notice history

Notice Type Posted
Verapamil Tablets Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity